AIRS
Airsculpt Technologies IncNASDAQHEALTHCAREMEDICAL CARE FACILITIES
Key Statistics
Market Cap
$376.01M
P/E Ratio
—
EPS
$-0.17
Beta
2.02
52W High
$12.00
52W Low
$1.51
50-Day MA
$3.22
200-Day MA
$4.51
Dividend Yield
—
Profit Margin
-7.39%
Forward P/E
—
PEG Ratio
—
About Airsculpt Technologies Inc
Airsculpt Technologies Inc (AIRS) is a pioneering company in the aesthetic medical technology sector, renowned for its innovative AirSculpt® procedure that delivers minimally invasive body contouring with a strong commitment to patient safety and comfort. The company is strategically expanding its network of licensed practitioners, supported by a robust focus on technological advancements, which positions Airsculpt favorably within the rapidly growing non-invasive cosmetic treatment market. As consumer demand for aesthetic solutions continues to rise globally, Airsculpt is well-positioned to enhance its market share and diversify its service offerings, aiming to achieve substantial growth and sustainable value for its investors.
Fundamentals
| Revenue (TTM) | $151.84M |
| Gross Profit (TTM) | $100.31M |
| EBITDA | $7.51M |
| Operating Margin | -4.58% |
| Return on Equity | -12.60% |
| Return on Assets | -1.60% |
| Revenue/Share (TTM) | $2.40 |
| Book Value | $1.42 |
| Price-to-Book | 3.74 |
| Price-to-Sales (TTM) | 2.48 |
| EV/Revenue | 2.825 |
| EV/EBITDA | 463.70 |
| Quarterly Earnings Growth (YoY) | 200.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $70.55M |
| Float | $9.96M |
| % Insiders | 43.06% |
| % Institutions | 66.04% |
Analyst Ratings
Consensus ($4.50 target)
2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026